Postoperative recovery from muscle weakness was investigated by handgrip strength after general anaesthesia using short-and long-acting muscle relaxants. Handgrip strength was measured on four occasions, preoperatively, before and after premedication, and postoperatively, both as soon as the patient could sustain a five-second headlift and one hour later. Twenty patients received either atracurium 0.6 mg/kg or pancuronium 0.1 mg/kg as part of a general anaesthetic technique with neostigmine reversal. Compared with their initial preoperative hand strengths, the two relaxant groups showed only an insignificant decrease in grip strength to 92% after premedication. Postoperatively when a five-second headlift was achieved, the patients in both groups were weak. The group given atracurium had a mean of 60% of their initial grip strength and those given pancuronium had a mean of 44%. This difference in strength was statistically significant from the initial level and from each other. However, there was no difference between the groups in the time intervalfram administering reversal to achieving a sustained headlift. One hour later in both groups grip strength was much better, within 80% of that seen after premedication in most patients, and no significant difference in grip strength was seen between the groups. This study demonstrates that patients who receive relaxant anaesthesia have substantial muscle weakness in the recovery phase. When neostigmine reversal is used, pancuronium appears to have a similar return of voluntary muscle power to that seen with atracurium. The marked difference in elimination kinetics of these two relaxants seems to be of little importance when neostigmine reversal is used.
may occur. This may be marked, resulting in a diminished tidal volume, and requiring prompt management by further reversal or respiratory support. Alternatively it may be less severe but still cause discomfort by diplopia, a feeling of weakness or a reduced reserve of muscle power. In patients such as day cases who may be mobile soon after their operation, it may make walking difficult or climbing stairs impossible.
There is little information on the degree of muscle weakness resulting from the usual clinical doses of muscle relaxants. Most investigations of the effect of relaxants have used measurement of muscle twitch, train-offour or tetanus by peripheral nerve stimulation for assessment, which is unlikely to detect levels of less than 50% receptor occupation by the relaxant. However, this occupancy may still impair voluntary muscle power. Probably the most sensitive test of neuromuscular junction transmission by peripheral nerve stimulation is a 200 Hz tetanus. However, this can be very painful in the awake patient and therefore cannot be used to assess progressive muscle recovery after anaesthesia. Voluntary handgrip is a simple painless alternative approach to measuring muscle power.
Recently the effect of the well-established, long-acting relaxants has been examined to determine how much impairment of muscle power remained during the early postoperative period. l Although post operatively voluntary muscle power was diminished by inhalational anaesthesia alone to 77% of initial strength, which probably represents a diminished effort by the patient, anaesthesia with relaxants resulted in a more marked weakness. After relaxant anaesthesia, when patients could sustain a five-second headlift, the hangrip force was only 29%±16 (mean, SO) of the preoperative strength. It might be expected that in clinical use the new shorter-acting relaxants would be less likely to show residual muscle weakness. We therefore decided to compare the residual weaknesses after short-and long-acting nondepolarising relaxants.
Atracurium was chosen as one of the nondepolarising neuromuscular blocking agents as in vivo it is rapidly degraded by Hofmann elimination and ester hydrolysis to inactive fragments. 2 It has a half-life of about 20 minutes 3 which is shorter than any other competitive agent. In contrast, pancuronium with a half-life of about 2-4 hours 4 was selected as the longer-acting relaxant because it is widely used in clinical practice in Australia. If, as commonly assumed, the plasma concentration of the relaxant relates to the degree of paralysis, a faster elimination should be associated with a faster recovery. This study assessed the voluntary muscle power after reversal by neostigmine of nondepolarising neuromuscular blockade from either atracurium or pancuronium.
METHODS
Twenty patients requiring neuromuscular blockade as part of a balanced anaesthetic technique gave informed consent to participation in the study which was approved by the hospital ethics committee. Patients were excluded who could not understand English, who had preoperative muscle weakness, who required suxamethonium for intubation or who had any evidence of hepatic or renal impairment. Patients were randomly allocated to receive either atracurium or pancuronium for neuromuscular blockade during anaesthesia.
Premedication was with oral temazepam 20 mg given 90 minutes preoperatively. Anaesthesia was induced with fentanyl 5 Ilg/kg followed by a sleep dose of thiopentone. After neuromuscular blockade with either atracurium 0.6 mg/kg or pancuronium 0.1 mg/kg was established, the patients were intubated and artificially ventilated. Anaesthesia was maintained with 67% nitrous oxide in oxygen and halothane up to 0.5% as clinically indicated. Increments of atracurium 10 mg or pancuronium 1 mg were given as clinically indicated. At the end of surgery residual neuromuscular block was antagonised with neostigmine 2.5 mg and atropine 1.2 mg. When respiration had returned, the patient was transferred to the recovery ward and placed on 70% oxygen for at least half an hour.
Handgrip force was assessed preoperatively before premedication, just before induction of anaesthesia, postoperatively as soon as the patient could sustain headlift for five seconds, and finally one hour after the five-second headlift. The handgrip force at each stage was measured as the mean of three maximal squeezes with each hand of a simple commercially available hand dynamometer, the 'My-Gripper' (Figure 1) . The force at each stage was expressed as a percentage of the mean initial preoperative value. The time interval between reversal of neuromuscular blockade and sustaining five-second headlift was also noted.
Statistical analysis was performed using Student's t test except for differences in the interval between reversal of neuromuscular blockade and sustaining five-second headlift which were analysed by the Mann-Whitney test for non-parametric data, as the groups were markedly asymmetric in their distribution.
RESULTS
Ten patients received atracurium and ten received pancuronium. The patients had an age range 29-80 years and a weight range 45-100 kg. The two groups of patients had a similar range of ages, 52.0 (SD 13.1) years, 53.3 (SD 20.3) years respectively (t = 0.17 P = 0.86) and weights 69.1 (SD 11. 7) kg and 76.0 (SD 17.1) kg respectively (t= 1.05 P = 0.31). All patients were able to obey simple commands in less than five minutes after reversal.
There was no difference between the two groups in the initial baseline grip force. The results of the later force measurements, expressed as a percentage of the baseline value and the results of the interval between reversal of neuromuscular blockade and sustaining headlift are summarised in Table 1 . Individual patterns are shown in Figure 1 and Figure 2 for atracurium and pancuronium respectively. Both groups showed a diminished grip force to a mean of 92% of their initial value following premedication but this change was not statistically significant. At the time a five-second headlift was achieved, the mean grip force was only 60% of the initial strength for the atracurium group and 44% for pancuronium group. Both groups were statistically highly significantly different from the starting values. Also there was a statistically significant difference at headlift in mean handgrip strength between the two groups (t = 1.80, 18 d.f., P= 0.042 one side) Table 1 . In addition there was a significant diminution of grip strength from the premedication measurement for both by 32.3% (13.5) (mean, SD) and 47.2% (23.3) respectively. The diminution with pancuronium was significantly greater than atracurium (t = 1. 77, 18 d.f., P = 0.046 one side). However, in both groups there was a wide variability in the power of muscle grip when headlift was achieved from 39%-82% for atracurium ( Figure 1 ) and 16%-79% for pancuronium ( Figure 2 ). .c:
Premedicatn
Head Lift One Hour In contrast, the rate of recovery as assessed by the time to achieve headlift was similar, the mean times being 20 and 19 minutes respectively. Again there was a wide range in both groups from a few minutes to about 1 % hours (0 = 46.5, P> 0.10 one tail). In both groups, 9 of the 10 subjects had achieved headlift within 40 minutes. This similarity in relaxant behaviour was reinforced by the similar recovery of strength in both groups to 83% and 78% of initial strength respectively one hour after achieving headlift (Table 1 ). In both, this was still . signficantly less than initially but most patients (9/10 atracurium, 8/10 pancuronium groups) had a mean grip strength within 80% of that measured after premedication and all had at least half their initial strength. There was no significant difference between the groups at this time.
DISCUSSION
In clinical practice, postoperative muscle weakness is the result of many causes and handgrip force is a physiological and painless method of assessing this overall weakness. Although it is dependent on the patient's own effort, and hence to some extent susceptible to sedation such as premedication, or postanaesthetic 'hangover', these are only modest effects. In this study, premedication reduced effort by a mean of 8%.
In both groups there was a marked degree of muscle weakness still present when the patient could sustain a five-second headlift. Thus even headlift appears to be a relatively insensitive indicator of 'normal' muscle power and can be achieved with marked voluntary weakness still present. The better muscle power of atracurium patients at headlift could be explained by the shorter pharmacokinetics, but it is puzzling as one would expect a similar muscle power when headlift was achieved and a faster recovery from that point, i.e. a greater return of muscle power one hour later. We do not feel this difference is due to inaccuracy in the method as the level of weakness found with pancuronium at headlift is similar with that found in the previous study.! An alternative hypothesis is that atracurium has a more selective effect on neck muscles compared to forearm voluntary muscles, but we know of no evidence on this point, and it seems fundamentally unlikely. We were able to show only modest differences between the residual effect of atracurium and pancuronium but this is unlikely to be due to any difference in dosing. Our initial doses were based on equipotent doses for intubation. 7 Top-ups were given on the basis of clinical assessment and were those commonly used in clinical practice. Even though the top-up dose ofatracurium is larger relatively than that of pancuronium, each is only 20%-30% of the loading dose. Even doubling a plasma level, because of the exponential decay, does not double the duration of action, and the imprecision in the small top-up dosing is thus unlikely to have played a major role in these results.
The time to achieve headlift is surprising. The similar times for both groups contradicts the pharmacokinetic profiles. With approximately a four to eightfold difference in half-life, any small overdosing of atracurium is unlikely to be the cause of this delay in return of muscle power. Also the very wide scatter of recovery times is of clinical significance. This span is similar for both relaxants and demonstrates the wide variability in patient response.
It appears that following general anaesthesia the return of muscle power is strongly influenced by factors other than the pharmacokinetics of the relaxant and although the spontaneous recovery from atracurium has been shown to be much faster than that of pancuronium,9 when neostigmine is used to antagonise the competitive block this kinetic difference appears to be unimportant. This may explain the similar reversal to headlift times. The similar grip strengths one hour later for each group may also reflect the ongoing neostigmine antagonism implying again that relaxant Anaesthesia and lmensil-'e Care, Vol. 16, No. 3, August, 1988 kinetics may be of limited significance in clinical practice.
This study establishes that major voluntary muscle weakness can be present in the early postoperative period with both short-and long-acting competitive muscle relaxants even when a patient can sustain a five-second headlift. One hour later, power has substantially returned whether a long-or short-acting relaxant has been given if neostigmine reversal has been used. It may be more appropriate to assess the neuromuscular recovery of patients by headlift and then allow a set one hour for muscle recovery rather than have a policy of a minimum fixed time in the recovery area.
